0001209191-23-021201.txt : 20230327 0001209191-23-021201.hdr.sgml : 20230327 20230327160502 ACCESSION NUMBER: 0001209191-23-021201 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230323 FILED AS OF DATE: 20230327 DATE AS OF CHANGE: 20230327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kiener Peter A CENTRAL INDEX KEY: 0001328146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 23764545 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-23 0 0001645460 Cue Biopharma, Inc. CUE 0001328146 Kiener Peter A C/O CUE BIOPHARMA INC. 40 GUEST STREET BOSTON MA 02135 1 0 0 0 0 Common Stock 2023-03-23 4 M 0 9682 2.86 A 9682 D Common Stock 2023-03-23 4 S 0 9325 3.28 D 357 D Stock Option (right to buy) 2.86 2023-03-23 4 M 0 9682 0.00 D 2023-03-23 Common Stock 9682 96062 D Sale to cover exercise price of cashless exercise of stock option. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. This Stock Option became exercisable in five equal annual installments beginning March 23, 2017 and is fully vested. This stock option expired on March 23, 2023. /s/ Peter Kiener by Colin Sandercock, attorney-in-fact 2023-03-27